A Retrospective Study Comparing Neutral Protamine Hagedorn Insulin With Glargine As Basal Therapy In Prednisone-Associated Diabetes Mellitus In Hospitalized Patients

Clore, 2009, Glucocorticoid-induced hyperglycemia, Endocr Pract, 15, 469, 10.4158/EP08331.RAR Abdelmannan, 2010, Effect of dexamethasone on oral glucose tolerance in normal individuals, Endocr Pract, 16, 770, 10.4158/EP09373.OR Gulliford, 2006, Risk of diabetes associated with prescribed glucocorticoids in a large population, Diabetes Care, 29, 2728, 10.2337/dc06-1499 Donihi, 2006, Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients, Endocr Pract, 12, 358, 10.4158/EP.12.4.358 Moore, 2006, The burden of new-onset diabetes mellitus after transplantation, Clin Transplant, 20, 755, 10.1111/j.1399-0012.2006.00565.x Pomposelli, 1998, Early postoperative glucose control predicts nosocomial infection rate in diabetic patients, JPEN J Parenter Enteral Nutr, 22, 77, 10.1177/014860719802200277 Malmberg, 1999, Circulation, 99, 2626, 10.1161/01.CIR.99.20.2626 Bloom, 2008, Transplant-associated hyperglycemia, Transplant Rev (Orlando), 22, 39, 10.1016/j.trre.2007.06.001 Inzucchi, 2006, Clinical practice. Management of hyperglycemia in the hospital setting, N Engl J Med, 355, 1903, 10.1056/NEJMcp060094 Menzin, 2010, Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus, J Manag Care Pharm, 16, 264, 10.18553/jmcp.2010.16.4.264 Umpierrez, 2002, Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes, J Clin Endocrinol Metab, 87, 978, 10.1210/jcem.87.3.8341 Hoogwerf, 1999, Drug selection and the management of corticosteroid-related diabetes mellitus, Rheum Dis Clin North Am, 25, 489, 10.1016/S0889-857X(05)70083-1 Braithwaite, 1996, Diabetes management during glucocorticoid therapy for nonendocrine disease, Endocr Pract, 2, 320, 10.4158/EP.2.5.320 Lucidi, 2011, Pharmacokinetics and pharmacodynamics of therapeutic doses of basal insulins NPH, glargine, and detemir after 1 week of daily administration at bedtime in type 2 diabetic subjects: a randomized cross-over study, Diabetes Care, 34, 1312, 10.2337/dc10-1911 Binder, 1984, Insulin pharmacokinetics, Diabetes Care, 7, 188, 10.2337/diacare.7.2.188 Umpierrez, 2007, Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial), Diabetes Care, 30, 2181, 10.2337/dc07-0295 Bazzano, 2008, Safety and efficacy of glargine compared with NPH insulin for the treatment of type 2 diabetes: a meta-analysis of randomized controlled trials, Diabet Med, 25, 924, 10.1111/j.1464-5491.2008.02517.x American Diabetes Association, 2012, Standards of medical care in diabetes-2012., Diabetes Care., 35, S11 Umpierrez, 2012, Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline, J Clin Endocrinol Metab, 97, 16, 10.1210/jc.2011-2098 Holman, 2009, Three-year efficacy of complex insulin regimens in type 2 diabetes, N Engl J Med, 361, 1736, 10.1056/NEJMoa0905479 King, 2010, No higher dose requirements with insulin detemir than glargine in type 2 diabetes: a crossover, double-blind, and randomized study using continuous glucose monitoring, J Diabetes Sci Technol, 4, 151, 10.1177/193229681000400119 Monami, 2009, Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis, Diabetes Obes Metab, 11, 372, 10.1111/j.1463-1326.2008.00976.x